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Abstract
The DNA recombination and repair machineries of Mycoplasma genitalium and Mycoplasma pneumoniae differ considerably
from those of gram-positive and gram-negative bacteria. Most notably, M. pneumoniae is unable to express a functional
RecU Holliday junction (HJ) resolvase. In addition, the RuvB homologues from both M. pneumoniae and M. genitalium only
exhibit DNA helicase activity but not HJ branch migration activity in vitro. To identify a putative role of the RuvA
homologues of these mycoplasmas in DNA recombination, both proteins (RuvAMpn and RuvAMge, respectively) were studied
for their ability to bind DNA and to interact with RuvB and RecU. In spite of a high level of sequence conservation between
RuvAMpn and RuvAMge (68.8% identity), substantial differences were found between these proteins in their activities. First,
RuvAMge was found to preferentially bind to HJs, whereas RuvAMpn displayed similar affinities for both HJs and single-
stranded DNA. Second, while RuvAMpn is able to form two distinct complexes with HJs, RuvAMge only produced a single HJ
complex. Third, RuvAMge stimulated the DNA helicase and ATPase activities of RuvBMge, whereas RuvAMpn did not augment
RuvB activity. Finally, while both RuvAMge and RecUMge efficiently bind to HJs, they did not compete with each other for HJ
binding, but formed stable complexes with HJs over a wide protein concentration range. This interaction, however, resulted
in inhibition of the HJ resolution activity of RecUMge.
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Introduction
A significant proportion of the genomes of Mycoplasma pneumoniae
and Mycoplasma genitalium (approximately 8% and 4%, respectively)
is composed of repeated DNA elements. These elements are
referred to as RepMP elements in M. pneumoniae [1,2,3] and MgPa
repeats (MgPars) in M. genitalium [4,5,6]. Although the different
variants of these elements show a high level of sequence homology,
they are not identical. Moreover, one or more of these variants are
contained within open reading frames (ORFs) that encode
antigenic surface proteins. Among these proteins are P1, P40
and P90 of M. pneumoniae and MgPa and P110 of M. genitalium.A s
these proteins can display amino acid sequence variation within
the regions encoded by the RepMP and MgPar sequences, it has
been proposed that this variation originates from recombination
between different variants of RepMP or MgPar
[7,8,9,10,11,12,13]. Consequently, homologous recombination
between the repeated DNA elements in both Mollicutes species
may play a crucial role in immune evasion [14].
It has previously been suggested that the mechanism of
recombination between repeated DNA elements in M. pneumoniae
and M. genitalium is similar to that of general homologous DNA
recombination in these species [15,16]. As a consequence, these
processes may utilize the same enzymatic machinery. Recent
studies that were aimed at elucidation of the mechanism of
recombination between repeated DNA elements therefore focused
on the characterization of Mycoplasma proteins predicted to be
involved in homologous DNA recombination, such as RecA [15],
single-stranded DNA-binding protein (SSB) [16], RuvA [17],
RuvB [18] and RecU [19,20]. The RecA proteins from M.
pneumoniae and M. genitalium (RecAMpn and RecAMge, respectively)
and the SSB protein from M. pneumoniae (SSBMpn) were reported to
possess similar activities as their counterparts from Escherichia coli
[15,16]. Both RecAMpn and RecAMge were found to catalyze the
exchange of homologous DNA strands in an ATP- and Mg
2+-
dependent fashion [15]. This activity was stimulated strongly by
SSBMpn, which is a tetrameric protein that selectively binds to
single-stranded DNA (ssDNA) [16].
In contrast to the SSB and RecA proteins, the RecU, RuvA and
RuvB proteins from M. pneumoniae and M. genitalium displayed in
vitro activities that differed considerably from those of their
counterparts from other bacterial classes. Specifically, the RecU
protein from M. genitalium (RecUMge) was found to diverge from
other Holliday junction (HJ) resolving enzymes in four major
aspects [19]. First and foremost, RecUMge only displayed HJ
resolvase activity in the presence of Mn
2+ and not in the presence
of Mg
2+. In contrast, the RecU homologue from Bacillus subtilis
(RecUBsu) and the RuvCEco and RusAEco resolvases from E. coli
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2+-dependent resolvase activity. Second, RecUMge has
a unique target DNA sequence, cleaving HJ substrates at the
sequence 59-
G/TCQPyTPuG-39. This cleavage site differs from
the cleavage sites of RecUBsu, RuvCEco and RusAEco
(59-
G/TGQC
A/C-39,5 9-
A/TTTQ
G/C-39 and 59-QCC-3, respec-
tively) [21,22,23,24,25]. Third, unlike the RecUBsu protein [21],
RecUMge is unable to anneal circular ssDNA to homologous, linear
double-stranded DNA (dsDNA). Fourth, RecUMge does not stably
bind to long ssDNA substrates, in contrast to the RecUBsu protein
[21].
Another crucial finding regarding the RecU orthologues from
M. pneumoniae and M. genitalium was the inability of M. pneumoniae to
produce a functional RecU protein [19,20]. While a subset of M.
pneumoniae strains (so-called subtype 2 strains) is able to express
a RecU homologue (RecUMpn), this protein was found to be
inactive in HJ-binding and -cleavage in vitro. Moreover, the other
major subset of M. pneumoniae strains (subtype 1 strains) was
reported to be incapable of producing a full-length RecU
homologue, due to the presence of a nonsense codon in the RecU
gene [19]. The inability of M. pneumoniae to produce a functional
RecU protein was suggested to be (one of) the causative factor(s) of
the relatively low level of homologous DNA recombination in this
bacterium [19].
Unique properties were recently also attributed to the RuvB
homologues from M. genitalium and M. pneumoniae (RuvBMge and
RuvBFH, respectively). In contrast to the E. coli DNA branch
migration motor protein RuvBEco, both RuvBMge and RuvBFH
were found to have RuvA-independent DNA helicase activity [18].
The activity of RuvBMge, however, was significantly lower than
that of RuvBFH. Interestingly, RuvBFH is exclusively expressed by
subtype 2 strains of M. pneumoniae. The RuvB protein expressed by
subtype 1 strains (RuvBM129) displays only marginal levels of DNA
helicase activity, due to a single amino acid substitution with
respect to RuvBFH [18]. Although RuvBFH did not appear to be
stimulated at all by M. pneumoniae RuvA (RuvAMpn), the helicase
activity of the RuvBMge protein was found to be promoted by M.
genitalium RuvA (RuvAMge) under specific reaction conditions [18].
The apparent inability of RuvAMpn to stimulate RuvBFH activity
can be caused by specific, aberrant features of the RuvBFH protein
in comparison with RuvBEco. Alternatively, RuvAMpn itself may be
unable to interact with, and/or activate, RuvBFH. In this regard, it
is interesting to note that RuvAMpn did not stimulate the branch
migration activity of RuvBEco in vitro, and could not functionally
substitute for RuvAEco in vivo (in E. coli) [17]. Thus, while the E.
coli RuvA protein has a vital role in the interaction with both RuvB
and the HJ resolving enzyme RuvC (within the RuvABC
resolvasome), the function of RuvAMpn within a putative branch
migration and resolution complex remains enigmatic.
In this study, the activities of RuvAMpn and RuvAMge are
characterized and compared. We show that these proteins differ
considerably in (i) their affinities for branched and non-branched
DNA substrates, (ii) complex formation with HJs, and (ii) their
interaction with other proteins from the DNA recombination
machinery.
Results
M. pneumoniae ORF MPN535 and M. genitalium ORF
MG358 encode RuvA homologues
The MPN535 ORF of M. pneumoniae was previously shown to
encode a RuvA homologue (RuvAMpn) [17]. A multiple amino acid
sequence alignment indeed shows significant similarities between
RuvAMpn and other (putative) RuvA proteins from gram-negative
and gram-positive bacteria (Fig. 1A). While the similarity between
the sequences of RuvAMpn and RuvAEco is relatively low (23.6%
identity), a high similarity is observed between the sequences of
RuvAMpn and RuvAMge (68.8% identity). In contrast to other
members of the putative DNA recombination apparatus of M.
pneumoniae, i.e. RecU and RuvB [18,19], RuvAMpn does not differ
in sequence among subtype 1 and subtype 2 strains.
Within the RuvA sequences, a relatively high level of amino
acid sequence conservation is found in two so-called helix-hairpin-
helix (HhH) motifs (Fig. 1A) [26]. These motifs were previously
identified within domain II of RuvAEco and were shown to be
crucial for sequence-independent DNA binding by interacting
with the DNA phosphate backbone of Holliday junctions (HJs)
[27,28,29]. The lowest level of sequence conservation was seen in
the region defined as the ‘flexible linker’, which separates domain
II from domain III in RuvAEco [30].
RuvAMge and RuvAMpn can bind to synthetic
oligonucleotide substrates
Both RuvAMge and RuvAMpn were expressed in E. coli as poly
histidine (H10)-tagged proteins and were purified to near
homogeneity using similar protocols (as described in Materials
and Methods). The H10-tagged proteins were found to have
activities that were indistinguishable from that of their non-tagged
counterparts (data not shown). Because the H10-tagged proteins
were obtained at higher concentrations and at a higher purity than
their ‘native’ versions (.95% versus ,90% homogeneity), they
were used throughout this study. The estimated molecular masses
of the purified proteins matched the theoretical molecular masses
of 23.7 kDa for both RuvAMge (Fig. 1B, lane 2) and RuvAMpn
(lane 3).
To test and compare the DNA-binding characteristics of
RuvAMge and RuvAMpn, both proteins were incubated with HJs,
double-stranded (ds) and single-stranded (ss) oligonucleotide
substrates, and analyzed by electrophoretic mobility shift assay
(EMSA). As described before [17], two distinct complexes
(complex I and complex II) were formed between RuvAMpn and
HJs in a protein-concentration dependent fashion (Fig. 2A).
Similar complexes were reported to be generated between
RuvAEco and HJs, and were found to consist of a single protein
tetramer (complex I) or a double tetramer (complex II) bound to
a HJ [30,31,32,33,34,35]. The HJ binding activity of both
RuvAMpn and RuvAMge was strongly reduced in the presence of
Mg
2+ (compare Fig. 2A to Fig. 2B, and Fig. 2C to Fig. 2D). A
similar inhibitory effect of Mg
2+ on DNA-binding activity has
previously also been observed for RuvAEco [31,36]. In contrast to
RuvAEco and RuvAMpn, RuvAMge produced only a single complex
with HJs (Fig. 2C, lane 6), even at protein concentrations up to
4 mM (see below). This complex migrated through the gels with
a mobility similar to that of RuvAMpn-HJ complex I. These data
indicated that: (i) the RuvAMge-HJ complex is composed of
a tetramer of RuvAMge bound to a HJ, and (ii) RuvAMge may not
stably bind to HJs as an octamer. These notions were supported by
gel filtration chromatography data, which indicated that RuvAMge
exists as a single, major protein species with a molecular mass of
,108 kDa (Fig. S1). This molecular mass corresponds to the
theoretical molecular mass of a tetramer of RuvAMge (95 kDa).
Thus, RuvAMge primarily exists as a homo-tetramer in solution.
In contrast to RuvAEco, RuvAMpn was previously reported to
form stable complexes with linear duplex oligonucleotides [17]. As
shown in Fig. 2E and 2F, both RuvAMpn and RuvAMge are able to
form DNA-protein complexes in the presence of ds oligonucleo-
tides (substrate HJ11/HJ11rv). Interestingly, at least part of these
complexes consisted of RuvA molecules bound to non-annealed, ss
oligonucleotide HJ11, which was present as a minor ‘contaminant’
The M. genitalium and M. pneumoniae RuvA Proteins
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Fig. 2E and 2F) was completely complexed by the RuvA proteins
at the highest protein concentrations tested (Fig. 2E, lane 4–6 and
Fig. 2F, lane 6). In a separate EMSA, we could confirm the
binding of RuvAMpn to oligonucleotide HJ11; this binding
appeared to occur with an efficiency similar to that observed with
the four-stranded HJ substrate (compare Fig. 2G to Fig. 2A).
Conversely, while the RuvAMge protein also displayed binding to
the ssDNA (Fig. 2H), this binding was considerably less efficient
than that observed with the HJ substrate (Fig. 2C).
The preferences of RuvAMpn and RuvAMge for binding to either
ssDNA or HJ DNA were further investigated in DNA-binding
competition experiments, in which a labeled DNA substrate was
kept at a constant concentration and another, unlabeled substrate
was included at different concentrations. As shown in Fig. 3A, the
binding of RuvAMge to the labeled HJ substrate was not
significantly influenced by inclusion of up to a 20-fold excess of
unlabeled ssDNA in the reaction (lanes 3–6). In contrast, the
binding of RuvAMpn to the HJ substrate was already clearly
reduced in the presence of a 2.5-fold excess of unlabeled ssDNA in
the binding reactions (Fig. 3B, lane 3). Although the dsDNA
substrate also competed with the HJ substrate for binding by
RuvAMpn, this competition was less efficient than that observed
with ssDNA (Fig. 3C). The high affinity of RuvAMpn for ssDNA
was further demonstrated in an experiment in which the binding
of RuvAMpn to labeled ssDNA was assayed in the presence of
different concentrations of unlabeled HJ substrate. As shown in
Fig. 3D, the ssDNA-binding of RuvAMpn was only marginally
Figure 1. Multiple alignment and purification of RuvAMpn and RuvAMge. (A) An alignment was generated with amino acid sequences
predicted to be encoded by the following ORFs (with GenBank accession numbers in parentheses), M. pneumoniae MPN535 (P75243), M. genitalium
G37 MG358 (Q49424), Streptococcus pneumoniae ruvA (Q97SY4), Staphylococcus aureus ruvA (Q5HFC1) and E. coli ruvA (P0A809). Predicted secondary
structural features and domains of the RuvA proteins are shown below the alignment and are based on the crystal structure of the RuvA protein from
E. coli [27,28,30,33,54]. The position of the ‘acidic pin’, between b sheets 6 and 7 of RuvAEco, two helix-hairpin-helix (HhH) motifs, and the flexible
linker (between domain II and III), are also indicated. The multiple alignment was performed using Clustal W (http://www.ebi.ac.uk/Tools/msa/
clustalw2/). The program BOXSHADE 3.21 (http://www.ch.embnet.org/software/BOX_form.html) was used to generate white letters on black boxes
(for residues that are identical in at least three out of five sequences) and white letters on grey boxes (for similar residues). (B) Purification of RuvAMge
and RuvAMpn. Samples of purified H10-tagged RuvAMge (lane 2) and H10-tagged RuvAMpn (lane 3) were analyzed by SDS-PAGE (12%) and Coomassie
brilliant blue (CBB)-staining. The sizes of protein markers (lane 1; PageRuler
TM Prestained Protein Ladder [Fermentas]) are shown on the left-hand side
of the figure in kDa.
doi:10.1371/journal.pone.0038301.g001
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PLoS ONE | www.plosone.org 3 May 2012 | Volume 7 | Issue 5 | e38301Figure 2. Binding of RuvAMpn and RuvAMge to HJs and other oligonucleotide substrates. (A) Binding of RuvAMpn to HJ substrate HJ 1.1 in
the absence of Mg
2+. The DNA-binding reactions were performed as indicated in Materials and Methods. Reactions were performed in volumes of
10 ml and contained 12.3 nM DNA substrate and either 0 nM (marked ‘-’, lane 1), 27 nM (lane 2), 81 nM (lane 3), 243 nM (lane 4), 729 nM (lane 5) or
The M. genitalium and M. pneumoniae RuvA Proteins
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molar excess of unlabeled HJ DNA in the reactions. Thus, in
contrast to RuvAMge (Fig. 2H and 3A), RuvAMpn is able to bind
with a relatively high affinity to ssDNA.
The interaction between RuvAMge and RecUMge on HJs
The RecU protein from M. pneumoniae (RecUMpn) was previously
found to be inactive in HJ-binding and -cleavage [19]. In contrast,
the M. genitalium RecU protein (RecUMge) was reported to be
a potent HJ-resolving enzyme [19,20]. Because it is possible that
RecUMge functionally interacts with RuvAMge in the processing of
HJs, both proteins were included in HJ binding and resolution
assays. The binding of RecUMge to HJ substrate HJ 1.1 was
previously demonstrated to result in a single DNA-protein
complex [19,20]. Interestingly, at relatively high RecUMge con-
centrations and at different binding conditions than those used
previously (i.e., binding on ice instead of at room temperature and
in the absence of BSA), a range of discrete RecUMge-HJ DNA-
protein complexes were generated, with an inverse correlation
between protein concentration and mobility of the complexes
through EMSA gels (Fig. 4A, lanes 2–4). At 500 nM of RecUMge,
three major DNA-protein complexes and one minor complex can
2.2 mM (lane 6) of RuvAMpn. Reaction products were electrophoresed through 8% polyacrylamide gels and analyzed by fluorometry. The positions of
unbound HJ 1.1 (Free HJ) and RuvAMpn/HJ complexes (Complex I and II) are indicated at the right-hand side of the gel. (B) Binding of RuvAMpn to HJ
substrate HJ 1.1 in the presence of 10 mM Mg
2+. Reactions were carried out in a similar fashion as in (A). (C, D). Binding of RuvAMge to HJ substrate HJ
1.1 in the absence (C) or presence of 10 mM Mg
2+ (D). (E, F) Binding of RuvAMpn (E) and RuvAMge (F) to double-stranded (ds) oligonucleotide HJ11/
HJ11rv. The positions of the ds substrate (Free ds) and residual non-annealed oligonucleotide HJ11 (Free ss) is indicated at the right-hand side of the
gels. (G, H) Binding of RuvAMpn (G) and RuvAMge (H) to single-stranded (ss) oligonucleotide HJ11. The reactions shown in panels (C) to (H) were carried
out similarly as in (A).
doi:10.1371/journal.pone.0038301.g002
Figure 3. DNA binding preferences of RuvAMge and RuvAMpn. (A) Binding of RuvAMge (3 mM) to HJ substrate HJ 1.1 (6-FAM-labeled on strand
HJ11) in the presence of various concentrations of unlabeled ssDNA (oligonucleotide HJ11). The molar excess of unlabeled DNA over labeled DNA in
the reactions was 06(lane 2), 2.56(lane 3), 56(lane 4), 106(lane 5) and 206(lane 6). The protein was added as final component in the reactions.
Protein was omitted from the reaction shown in lane 1. The positions of the free HJ substrate (Free HJ) and RuvAMge-HJ complexes (Complex) are
indicated at the right-hand side of the gel. (B) Binding of RuvAMpn (3 mM) to HJ substrate HJ 1.1 (6-FAM-labeled on strand HJ11) in the presence of
various concentrations of unlabeled ssDNA (oligonucleotide HJ11). The experiment was performed similarly as in (A). The two major RuvAMpn-HJ
complexes (Complex I and II) are indicated at the right-hand side of the gel. (C) Binding of RuvAMpn (3 mM) to HJ substrate HJ 1.1 (6-FAM-labeled on
strand HJ11) in the presence of various concentrations of unlabeled dsDNA (oligonucleotide HJ11/HJ11rv). The experiment was performed similarly
as in (A). The two major RuvAMpn-HJ complexes (Complex I and II) are indicated at the right-hand side of the gel. (D) Binding of RuvAMpn (3 mM) to
ssDNA (6-FAM-labeled oligonucleotide HJ11) in the presence of various concentrations of HJ DNA (HJ 1.1). The experiment was performed similarly as
in (A). Protein was omitted from the reaction shown in lane 1. The positions of the unbound ssDNA (Free ssDNA) and RuvAMpn-ssDNA complex
(Complex) are indicated at the right-hand side of the gel.
doi:10.1371/journal.pone.0038301.g003
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also observed after binding of E. coli resolvase RusA to HJ
substrates [25]. Due to the distinct nature of the RecUMge-HJ
complexes and their relative migration in the gel, we hypothesize
that they represent different multimeric forms of RecUMge, bound
to a single HJ substrate. Upon addition of RuvAMge to these
complexes (after preincubation of RecUMge with the HJ substrate),
novel complexes were formed with a considerably slower mobility
than the RecUMge-HJ complexes (Fig. 4B, lanes 3–7). At the
highest concentration of RuvAMge used (4 mM), all RecUMge-HJ
complexes appeared to have shifted to a higher position in the gel
(lane 7). Because the novel complexes had a slower mobility than
the RuvAMge-HJ complex (Fig. 4B, lane 8), it is likely that they
represent HJs bound by both RecUMge and RuvAMge. This notion
was corroborated by a reciprocal experiment in which the HJ
substrate was preincubated with RuvAMge (at 4 mM), followed by
the addition of RecUMge at concentrations ranging from 0 nM to
500 nM (Fig. 4C, lanes 2–7). Already at a RecUMge concentration
of 31 nM (lane 3), a ‘supershift’ of the RuvAMge-HJ complex was
observed; this supershift was virtually complete at a RecUMge
concentration of 250 nM (lane 6). At the latter concentration,
a single major supershifted complex was observed. At 500 nM of
RecUMge, however, four discrete supershifted complexes were
formed, which corresponded in mobility with the complexes
generated in the previous experiment (Fig. 4B, lane 7). Again, the
supershifted complexes displayed a slower mobility than did the
RecUMge-HJ and RuvAMge-HJ complexes (Fig. 4C, lanes 2 and 8),
indicating that they indeed represent RecUMge-RuvAMge-HJ
complexes. The interactions between RecUMge and RuvAMge on
HJ substrates differ significantly from those reported between
RuvAEco and the RuvC resolvase from E. coli (RuvCEco).
Specifically, RuvAEco appears to have a significantly higher affinity
than RuvCEco for HJ substrates, and a fully saturated RuvAEco-HJ
complex (complex II) cannot be bound detectably by RuvCEco
[32]. As a consequence, RuvACEco-HJ complexes are only
observed at relatively low RuvAEco concentrations (1–20 nM); at
higher RuvAEco concentrations, RuvACEco-HJ and RuvCEco-HJ
complexes are either not formed or rapidly dissociated [32]. In
contrast, RecUMge and RuvAMge do not appear to compete with
each other in HJ binding, but rather associate readily and stably
on a HJ substrate at a wide range of concentrations of both
RuvAMge (Fig. 4B) and RecUMge (Fig. 4C). As yet, the multimeric
protein composition of the different RecUMge-RuvAMge-HJ com-
plexes is unknown. Nevertheless, while a single stable complex is
generated between RuvAMge and HJs, it is likely that each of the
RecUMge-RuvAMge-HJ complexes only contains a single tetramer of
RuvAMge.
RuvAMge inhibits HJ resolution by RecUMge
Because RuvAMge readily binds to RecUMge-HJ complexes, we
investigated the influence of RuvAMge on the activity of RecUMge in
HJ resolution assays. In these assays, substrate HJ 1.1 was
preincubated on ice with either RecUMge (at 0.2 mM; Fig. 5A) or
RuvAMge (at 0 to 4 mM; Fig. 5B), followed by the addition of the
other protein. After incubation for 30 min at 37uC, the resolution
products were analyzed by polyacrylamide gel electrophoresis. As
shown in Fig. 5A and 5B, RuvAMge inhibited the resolution activity
of RecUMge in a RuvAMge concentration-dependent fashion. The
inhibition of HJ resolution was most effective when RuvAMge was
added to the HJ substrate before RecUMge (Fig. 5B and 5C). In that
case, HJ resolution by RecUMge was already inhibited by ,20% at
a RuvAMge concentration of 60 nM (Fig. 5B, lane 3 and Fig. 5C).
At RuvAMge concentrations of 1 mM or higher, RecUMge activity
was reduced by $80% (Fig. 5B, lanes 7–9). When the HJ substrate
was incubated with RecUMge before the addition of RuvAMge,
a significant inhibition of HJ resolution activity ($20%) was only
observed at RuvAMge concentrations of $250 nM (Fig. 5A and
5C). Moreover, inhibition levels of .80% were not observed at
RuvAMge concentrations lower than 4 mM. When RecUMge and
RuvAMge were added simultaneously to the HJ substrates, a similar
pattern of HJ resolution was observed as that shown in Fig. 5A (in
which RecUMge was added to the reactions before RuvAMge). This
finding corroborates the notion that RecUMge-HJ complexes
cannot be dissociated by RuvAMge. Despite the significantly
different dynamics in the formation of RecUMge-RuvAMge-HJ
complexes and RuvACEco-HJ complexes, RuvAMge inhibits the
resolution activity of RecUMge in a similar fashion as RuvAEco
inhibits RuvCEco activity.
The influence of the RuvA proteins on the activities of
RuvBFH and RuvBMge
The RuvB protein that is expressed by M. pneumoniae subtype 2
strains, RuvBFH, was recently reported to act as a DNA helicase
on specific, partially double-stranded DNA substrates [18].
Interestingly, while this activity of RuvBFH was not influenced
by RuvAMpn, the RuvB protein from M. genitalium, RuvBMge, did
show RuvAMge-dependent helicase activity. The latter activity,
however, was only detected on a single helicase substrate, i.e.
Substrate IV from Fig. 6A [18]. To further delineate the functional
interactions between the RuvA and RuvB proteins from M.
pneumoniae and M. genitalium, the proteins were combined at various
concentrations (including considerably higher RuvA concentra-
tions than used previously) in DNA helicase or branch migration
assays, using the DNA helicase substrates shown in Fig. 6A. While
the helicase activity of RuvBFH was not influenced by RuvAMpn
(data not shown), the helicase activity of RuvBMge on Substrate II
(Fig. 6B and 6C) and Substrate I (Fig. 6D) was stimulated in the
presence of high concentrations of RuvAMge. As expected,
RuvAMge alone did not display any DNA helicase activity (lane 7
in Fig. 6C and 6D). This stimulatory effect of RuvAMge was
observed at various concentrations of RuvBMge, from 0.9 mM
(Fig. 6B) to 2.7 mM (Fig. 6C). These results indicated that the
activation of RuvBMge by RuvAMge is a general phenomenon that is
not restricted to a specific DNA substrate. Nevertheless,
irrespective of the presence of high concentrations of the RuvA
proteins, both RuvBMge and RuvBMpn were unable to unwind
small, double-stranded oligonucleotide substrates (data not shown).
The ATPase activity of RuvBMge is stimulated by RuvAMge
While RuvBFH and RuvBMge were previously found to possess
intrinsic ATPase activity, this activity was significantly higher for
RuvBFH than for RuvBMge [18]. To investigate whether the
ATPase activities of the RuvB proteins can be modulated by their
corresponding RuvA proteins, ATPase assays were carried out in
which the RuvA and RuvB proteins were tested together. In
accordance with previous findings [18], RuvBFH was found to
possess a significantly higher ATPase activity than RuvBMge (Fig. 7).
However, while the activity of RuvBFH was not significantly
influenced by RuvAMpn, the activity of RuvBMge was strongly
stimulated by RuvAMge. Thus, the ATPase activities of RuvBFH
and RuvBMge directly reflect the DNA helicase activities of these
proteins in two important aspects. First, the intrinsic enzymatic
activity of RuvBFH is higher than that of RuvBMge. Second,
RuvBMge activity can be stimulated by RuvAMge, whereas RuvBFH
activity is not influenced by RuvAMpn. As expected, both RuvAMpn
and RuvAMge did not show any ATPase activity on their own
(Fig. 7).
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The DNA recombination and repair machineries of mycoplas-
mas differ considerably from those of gram-positive and gram-
negative bacteria. Most importantly, in contrast to the latter
micro-organisms, mycoplasmas do not possess homologues of
LexA, RecBCD, AddAB, RecQ, RecJ and RecF [37,38]. In
addition, some components of the putative DNA recombination
machineries of M. pneumoniae and M. genitalium were found to have
characteristics that diverge from those of their homologues from
other bacterial classes. These components include the RecU and
RuvB proteins [18,19,20]. In Table 1, the characteristics of these
as well as the other (putative) components of the DNA re-
combination machineries of M. pneumoniae and M. genitalium are
listed and compared.
We here report that the RuvA proteins from both Mycoplasma
spp., RuvAMge and RuvAMpn, also possess exceptional properties as
opposed to their well-characterized counterpart from E. coli,
RuvAEco. While both RuvAMge and RuvAEco [31,39] preferentially
bind to HJs, RuvAMpn displayed a high affinity for both HJ and
ssDNA. In addition, while RuvAMpn and RuvAEco are both able to
form two distinct complexes with HJ substrates, RuvAMge only
formed a single complex with HJs. As this RuvAMge-HJ complex
had a similar mobility through polyacrylamide gels as RuvAMpn-HJ
complex I and RuvAEco-HJ complex I [17,30,31,32,33,34,35], and
because RuvAMge is a tetramer in solution, it is highly likely that
this complex is composed of a tetramer of RuvAMge bound to
a single HJ. This implies that RuvAMge may only stably bind to HJs
as a tetramer. This notion can have important consequences for
the interaction of the RuvAMge-HJ complex with other proteins
that are potentially targeted to HJs, such as RuvBMge and RecUMge.
It was previously reported that the ability of RuvAEco to form
stable octamers on HJs was vital for full activity of the protein.
This notion was inferred from the activities of four different
octamerization-deficient RuvAEco mutants [34,35,40]. Three of
these mutants carried amino acid substitutions in a protein region
known to be involved in tetramer-tetramer interactions [34,35,40].
This region was identified within the crystal structure of HJ-bound
octamers of the Mycobacterium leprae RuvA protein (RuvAMle) [33].
Within this structure, the two RuvA tetramers make direct
protein-protein contacts through specific amino acid side chain
interactions at four equivalent points, which are localized to the a6
helix of domain II (Fig. 1A). The interacting a6 helices from two
RuvA monomers are in an antiparallel configuration, such that ion
pair interactions are formed between three pairs of amino acid
residues. On the basis of sequence alignments, we predict that only
two of such pairs may be formed between two antiparallel a6
helices of both RuvAMge and RuvAMpn. In RuvAMpn, these pairs
would consist of Lys121-Asp133 and Arg124-Glu130, whereas in
RuvAMge, they would consist of Lys121-Glu133 and Arg124-
Glu130. While this prediction emphasizes the sequence similarity
between RuvAMpn and RuvAMge, it does not provide an
explanation why RuvAMpn is able to form stable octameric
complexes with HJs, and RuvAMge is not. It should be considered,
Figure 4. The interaction between RuvAMge and RecUMge on HJs. (A) HJ-binding by RecUMge. The DNA-binding reactions were performed in
a similar fashion as described in Fig. 3. Reactions were performed in volumes of 10 ml and contained 12.3 nM HJ 1.1 and the indicated concentrations
of RecUMge. The positions of unbound HJs (HJ) and RecUMge-HJ complexes are depicted at the right-hand side of the gel. (B) The binding of RuvAMge
to RecUMge-HJ complexes. RecUMge (0.5 mM) was incubated with HJ 1.1, followed by the addition of RuvAMge (at different concentrations, as indicated
above the lanes). The nature of the various protein-DNA complexes is indicated at the right-hand side of the gel; RuvAMge-HJ complexes are indicated
with a dot (N). (C) The binding of RecUMge to RuvAMge-HJ complexes. RuvAMge (4 mM) was incubated with HJ 1.1, followed by the addition of RecUMge
(at various concentrations, as indicated above the lanes). The labeling of the figure is similar to that shown in (B).
doi:10.1371/journal.pone.0038301.g004
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absent from RuvAMge) may differ considerably from those of
RuvAMle, and are not (solely) determined by contacts between
amino acid residues located in the a6 helix. In this regard, it is
relevant to note that one of the reported RuvAEco mutants that is
unable to form stable octamers on HJs, RuvAz87, does not carry
mutations in helix a6, but in two other regions of the protein, i.e. in
the region between helices a2 and a3 and in helix a4 [40].
Despite its inability to octamerize on HJs in a stable fashion,
RuvAMge was found to stimulate the DNA helicase and ATPase
activities of RuvBMge. The octamerization-competent RuvAMpn
protein, however, did not augment RuvBFH activity. It is possible
that the relatively high intrinsic DNA helicase activity of RuvBFH
obscured the observation of any additional stimulatory effect on
this protein by RuvAMpn. An alternative explanation for the
inability of RuvAMpn to boost RuvBFH activity is that these proteins
are unable to physically interact. In agreement with this notion, we
have not yet been able to detect direct or indirect interactions
between these proteins in DNA-binding studies.
Another unique feature of RuvAMge is the mode in which this
protein forms tripartite complexes with HJ resolvase RecUMge and
HJs. This is the first report to demonstrate an interaction between
a member of the RecU protein family and a RuvA protein.
RuvAMge and RecUMge were found to associate readily and stably
on HJ substrates at a broad protein concentration range. In
contrast, tripartite complexes of RuvAEco, RuvCEco and HJs were
only observed at relatively low concentrations of RuvAEco, because
the latter protein has a higher affinity than RuvCEco for HJ DNA
[32]. At relatively high RuvAEco concentrations, the HJ DNA will
be saturated with protein, such that two RuvAEco tetramers are
bound to opposite faces of the junction. Thus, the binding of
RuvCEco to the junction is excluded [32,33,41]. At low RuvAEco
concentrations, however, the main protein-HJ complex that is
formed is complex I, which consists of a single tetramer of
RuvAEco bound to a single face of the junction. This structure may
allow the binding of a RuvCEco dimer to the other face of the DNA
substrate, thereby generating a tripartite RuvACEco-HJ complex
[32]. In analogy with this model, a tetramer of RuvAMge bound to
one side of a HJ may permit the binding of (multimers of) RecUMge
at the opposite side of the junction. Because RuvAMge is unable to
form stable octameric-HJ complexes, as discussed above, the
tetrameric RuvAMge-HJ complex may always be accessible, at one
face of the junction, for binding by RecUMge. This may explain
why RecUMge and RuvAMge do not compete with each other for
binding to HJs, but rather interact readily by forming a stable
tripartite complex. This interaction does, however, lead to
inhibition of the HJ resolution activity of RecUMge, a phenomenon
that parallels the inhibition of RuvCEco-catalyzed HJ resolution by
Figure 5. RuvAMge inhibits HJ resolution by RecUMge. (A, B) HJ resolution assays [19] were performed in volumes of 10 ml and contained
12.3 nM HJ substrate HJ 1.1 (6-FAM-labeled), RecUMge (0.2 mM) and various concentrations of RuvAMge, as indicated above the lanes. Reactions were
preincubated for 2 min with either RecUMge (A) or RuvAMge (B), followed by addition of the other protein. After incubation for 30 min at 37uC, the
reaction products were separated on 12% polyacrylamide gels, and analyzed by fluorometry. The locations of the HJ substrate and resolution
products are indicated schematically at the right-hand side of the gels. (C) Quantification of the influence of RuvAMge on RecUMge activity. The relative
RecUMge (resolution) activity was measured from the gels shown in (A) and (B) and expressed as percentage of the protein’s activity in the absence of
RuvAMge. The data from (A) and (B) are represented by the closed squares (&) and the open squares (%), respectively.
doi:10.1371/journal.pone.0038301.g005
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RuvAMge-HJ complexes are stabilized exclusively by protein-DNA
interactions or also by RecUMge-RuvAMge interactions; experiments
aimed at the detection of such protein-protein interactions have
hitherto not produced conclusive results. In addition, it is clear
that the physiological role will have to be established of the
RecUMge-RuvAMge interaction and the RuvAMge-mediated inhibi-
tion of the HJ resolution activity of RecUMge. Nevertheless, it is
likely that a functional coupling exists between these proteins and
that the combined activities of a complex of RuvBMge and RuvAMge
may be linked to the resolvase activity of RecUMge. Such a situation
could be similar to that in E. coli, in which the RuvAB DNA
branch migration complex is coupled to the RuvC resolvase in
a RuvABCEco resolvasome complex. In this regard, it is also
interesting to note that a close association between RecUMge and
RuvAMge (plus RuvBMge) is also reflected in the genome of M.
genitalium, in which the ORF encoding RecUMge (MG352) is
localized in the vicinity of the ORFs encoding RuvAMge (MG358)
and RuvBMge (MG359).
Another issue that remains to be addressed is the nature of the
four different RecUMge-HJ complexes that were formed at
relatively high concentrations of RecUMge. In previous studies on
this protein, only a single RecUMge-HJ complex was observed due
to the use of different DNA binding conditions [19,20]. It was
shown by protein crystallography and structure determination that
the RecU homologues from Bacillus subtilis [42] and Bacillus
stearothermophilus [43] exist as dimers. Based on this information, we
speculate that the four RecUMge-HJ complexes that were observed
in this study consist of HJs bound by dimers, tetramers, hexamers
and octamers, respectively, of RecUMge. How the larger multimers
would be accommodated on a single HJ, and how these would also
leave room for binding of a RuvAMge tetramer, which was
observed for each of the four RecUMge-HJ complexes, are
challenging questions. The formation of large assemblies of
proteins bound to a junction, however, is not unprecedented, as
RuvAEco mutant RuvA3m was reported to generate HJ-protein
complexes consisting of six protein tetramers [35].
In conclusion, the studies of the RuvA, RuvB and RecU
homologues from mycoplasmas have revealed that these proteins
each have distinctive properties as opposed to their counterparts
from other bacterial classes. It is possible that these unique features
have emerged as a consequence of the evolutionary reduction that
the genomes of the mycoplasmas are believed to have undergone.
Specifically, the loss of a significant portion of an ancestral set of
Figure 6. The influence of RuvAMge on the DNA helicase activity of RuvBMge. (A) Schematic illustrations of the DNA substrates used in the
DNA helicase assays. The substrates are composed of a combination of oligonucleotides (oligonucleotide 1, oligonucleotide 2 or oligonucleotide 2/1)
and single-stranded, circular 5,386-bp wX174 DNA, as described previously [18]. (B, C) RuvAMge stimulates the DNA helicase activity of RuvBMge on
Substrate II. Substrate II, 6-FAM-labeled at the 59 end of oligonucleotide 1, was incubated with either 0 mM, 0.9 mM (B) or 2.7 mM (C) of RuvBMge in the
presence of various concentrations of RuvAMge, as indicated above the lanes. (D) RuvAMge stimulates the DNA helicase activity of RuvBMge on
Substrate I. Substrate I, 6-FAM-labeled at the 59 end of oligonucleotide 1, was incubated with either 0 mM (lanes 1 and 7) or 1.6 mM of RuvBMge in the
presence of various concentrations of RuvAMge, as indicated above the lanes. After the reaction (5 min at 37uC), the samples were deproteinized,
electrophoresed through native 12% polyacrylamide gels, and analyzed by fluorometry. The positions of the substrates, which are too large to enter
the gels, as well as the positions of the oligonucleotide reaction products, are indicated at the right-hand side of the gels by schematic illustrations. In
these illustrations, the position of the 6-FAM label is indicated by a black dot.
doi:10.1371/journal.pone.0038301.g006
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accompanying modification of the function of the RuvA, RuvB
and RecU proteins in order to preserve certain functionalities of
the recombination and repair system. Nevertheless, the complete
set of functions of this system in mycoplasmas is yet to be
determined. In this regard, it is particularly interesting to learn
how DNA recombination processes are achieved in M. pneumoniae
in the absence of a functional RecU resolvase [19]. Although HJ
resolvase activities may be exerted by other proteins, such proteins
have not yet been identified in M. pneumoniae. Moreover, the lack of
a functional RecU was proposed as a possible cause of the
relatively low frequency of homologous DNA recombination
events in M. pneumoniae [19]. Also, the HJ resolvase deficiency of
M. pneumoniae may be associated with the difference between M.
pneumoniae and M. genitalium in the specific mechanism by which
homologous DNA recombination events occur in these species. In
M. genitalium, the repeated DNA elements appear to recombine
predominantly in a reciprocal fashion [7,8,12], whereas in M.
pneumoniae such elements seem to recombine via a gene conversion-
like mechanism, in which donor sequences are copied to the
acceptor site and the original acceptor sequence is lost
[9,10,11,13,14]. To address these and other issues related to the
mechanism of homologous recombination in M. pneumoniae and M.
genitalium, it is crucial that the entire set of putative DNA
recombination and repair enzymes of these species be delineated.
This will therefore be the goal of future studies.
Materials and Methods
Cloning of the M. pneumoniae MPN535 gene and M.
genitalium MG358 gene
Bacterial DNA was purified from cultures of M. pneumoniae strain
M129 (ATCCH no. 29342
TM) and M. genitalium strain G37
(ATCCH no. 33530
TM), as described previously [16,44]. The
MPN535 ORF of M. pneumoniae strain M129, which encodes
a RuvA homologue, was amplified by PCR. The PCR reaction
was performed using the following primers: RuvAmpn_fw (59-
GGTCGTCATATGATTGCTTCAATTTTTGGAA-39, which
overlaps with the translation initiation codon [underlined] of
MPN535) and primer RuvAmpn_rev (59- GCAGCCGGATCCT-
TAGGCGGTTTTATTTGTAAC-39, which overlaps with the
antisense sequence of the translation termination codon [under-
lined] of the gene). The resulting 0.6-kilobase pairs (kb) PCR
fragment was digested with NdeI and BamHI (the recognition sites
for these enzymes are indicated in italics in the sequences of
primers RuvAmpn_fw and RuvAmpn_rev, respectively), and
cloned into NdeI- and BamHI-digested E. coli protein expression
vectors, i.e. pET-11c and pET-16b (Novagen), generating
plasmids pET-11c-RuvAMpn and pET-16b-RuvAMpn, respectively.
Plasmid pET-11c-RuvAMpn was used for expression of native
RuvAMpn, while plasmid pET-16b-RuvAMpn was employed for
expression of RuvAMpn as an N-terminally poly histidine (H10)-
tagged protein in E. coli.
Before cloning of the MG358 ORF of M. genitalium into E. coli
protein expression vectors, a TGA codon within the ORF
(encoding the Trp residue at position 27 of RuvAMge) was changed
into a TGG codon using a PCR-based mutagenesis procedure
[19]. Following mutagenesis, MG358 was amplified by PCR using
the primers RuvAmg_pETfw (59-CGTCACATATGATTACATC-
TATCTTTGG -39, which includes an NdeI restriction site [in
italics] and the translation initiation codon of MG358 [under-
lined]) and RuvAmg_pETrv 59-CGTCAGGATCCGGTAT-
TAGGCGGTTTTATTTG-39, which includes a BamHI site [in
italics] and the antisense sequence of the translation termination
codon [underlined] of the gene). The 0.6-kb PCR product was
digested with NdeI and BamHI, and ligated into NdeI- and BamHI-
digested vectors pET-11c and pET-16b, resulting in plasmids
pET-11c-RuvAMge and pET-16b-RuvAMge, respectively. These
plasmids were used for expression of native and H10-tagged
RuvAMge, respectively, in E. coli. The integrity of all DNA
constructs used in this study was checked by dideoxy sequencing,
as described before [15].
Figure 7. The influence of RuvAMpn and RuvAMge on the ATPase activities of RuvBFH and RuvBMge, respectively. ATP hydrolysis by
RuvBFH and RuvBMge was measured at a protein concentration of 0.5 mM, either in the absence of presence of the corresponding RuvA protein (at
1 mM). The ATPase activity was determined using an NADH-coupled assay. In this assay, the activity is calculated from the stationary velocities of ATP
hydrolysis, as determined by monitoring the absorption of NADH at 340 nm [15,46]. The ‘no protein’ reaction (6) indicates a control reaction
performed in the absence of any protein. (+), RuvAMge alone; (#), RuvAMpn alone; (%), RuvBMge alone; (&), RuvBMge plus RuvAMge;( n), RuvBFH alone;
(m), RuvBFH plus RuvAMpn. The graph shows a representative experiment.
doi:10.1371/journal.pone.0038301.g007
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The various pET-11c- and pET-16b-derived vectors were
introduced into E. coli BL21(DE3) and the resulting strains were
grown overnight at 37uC in LB medium containing 100 mg/ml
ampicillin. The cultures were diluted 1:100 in 300 ml LB medium
with ampicillin and grown at 37uC to an optical density at 600 nm
of 0.6. Protein expression was then induced by the addition of
isopropyl-b-D-thiogalactopyranoside (IPTG) to a final concentra-
tion of 0.5 mM. After incubation for 2 hr at 30uC, the bacteria
were harvested by centrifugation and stored at 220uC.
The H10-tagged RuvAMpn and RuvAMge proteins were both
purified using the following protocol. Bacterial pellets were
resuspended in 10 ml of buffer A (20 mM Tris-HCl pH 8.0,
1 M NaCl) containing 0.5 mg/ml of lysozyme. The suspension
was sonicated on ice and clarified by centrifugation for 20 min at
12,0006g (at 4uC). To the supernatant, imidazole was added to
a final concentration of 5 mM. Then, the supernatant was loaded
onto a column containing 1 ml of Ni
2+-nitroloacetic acid (Ni-
NTA)-agarose (Qiagen), which was equilibrated previously in
buffer A containing 5 mM imidazole. The column was washed
with 5 ml of buffer A plus 5 mM imidazole and with 5 ml of buffer
A plus 20 mM imidazole. The specifically bound proteins were
eluted from the column with 8 ml of buffer A containing 250 mM
imidazole. Fractions of 0.5 ml were collected, analyzed by SDS-
polyacrylamide gel electrophoresis (SDS-PAGE), pooled, and
dialyzed against a solution of 20 mM Tris-HCl (pH 7.4), 0.2 M
NaCl, 0.1 mM EDTA, 1 mM DTT and 50% glycerol (buffer B).
Aliquots of purified protein, which had an estimated homogeneity
of .95%, were stored at 220uC.
The native RuvA proteins were purified by solubilization of the
bacterial pellets in a buffer containing 20 mM Tris-HCl pH 7.5,
1 mM EDTA, 1 mM DTT and 0.5 mg/ml of lysozyme. After
sonication and centrifugation (using similar procedures as de-
scribed above), the RuvA proteins were precipitated with
ammonium sulphate and resuspended in 20 mM Tris-HCl pH
7.4, 0.1 M NaCl, 0.1 mM EDTA, 1 mM DTT. The proteins were
then subjected to affinity chromatography using Heparin Sephar-
ose 6 Fast Flow (GE Healthcare). Proteins were eluted from the
column material with a linear gradient from 0 M to 1 M NaCl in
20 mM Tris-HCl pH 7.4, 0.1 mM EDTA and 1 mM DTT. The
RuvA-containing fractions were pooled, dialyzed against buffer B,
and stored at 220uC.
The purifications of RecUMge, RuvBFH and RuvBMge have been
described before [18,19,20].
SDS-PAGE
Proteins were separated by SDS-PAGE, as described by
Laemmli [45]. Gels were stained with Coomassie brilliant blue
(CBB), destained in 40% methanol/10% acetic acid, and recorded
using a GelDoc XR system (Bio-Rad). Digital images were
processed using Quantity OneH 1-D Analysis Software (Bio-Rad).
DNA substrates
The small DNA substrates that were used in the DNA binding
experiments consisted of synthetic oligonucleotide substrates that
were 59 6-FAM-labelled on a single strand. Holliday junction (HJ)
substrate HJ 1.1, single-stranded oligonucleotide HJ11 and
double-stranded substrate HJ11/HJ11rv have been described by
Sluijter et al. [19]. Substrate HJ 1.1 is composed of the following
four oligonucleotides: HJ11 (59-GCGACGTGATCACCAGAT-
GATTGCTAG-GCATGCTTTCCGCAAGAGAAGC-39), HJ12
(59-GGCTTCTCTTGCGGAAAGCATGCCTA-
GCAATCCTGTCAGCTGCATGGAAC-39), HJ13 (59-
GGTTCCATGCAGCTGACAGGATT-GCTAGGCT-
CAAGGCGAACTGCTAACGG-39) and HJ14 (59-AC-
CGTTAGCAGTTCG-CCTTGAGCCTAGCAAT-
CATCTGGTGATCACGTCGC-39). The sequence of
oligonucleotide HJ11rv is 59-GGCTTCTCTTGCGGAAAG-
CATGCCTAGCAATCATCTGGTGATCACGTC-GC-39. The
DNA helicase substrates (Fig. 6A) have been described in detail by
Esteva ˜o and coworkers [18].
DNA-binding assays
Binding of the RuvA proteins to various DNA substrates was
carried out in 10-ml volumes and included 20 mM Tris-HCl pH
7.5, 1 mM DTT, 1 mM EDTA, 12.3 nM oligonucleotide sub-
strate and various concentrations of RuvA proteins. After in-
cubation on ice for 10 min, 1 ml was added of a solution
containing 40% glycerol and 0.25% bromophenol blue. Then,
the reaction mixtures were electrophoresed through 8% poly-
acrylamide gels in 0.56 TBE buffer (45 mM Tris, 45 mM boric
acid, 1 mM EDTA). Following electrophoresis, the polyacryl-
amide gels were analyzed by fluorometry, using a Typhoon
Trio
TM 9200 Variable Mode Imager (GE Healthcare) in
combination with the Typhoon Scanner Control v4.0 software
(Amersham Bioscience). Images were processed using Quantity
OneH 1-D Analysis Software.
Holliday junction (HJ) resolution assays
HJ resolution assays were carried out as described by Sluijter
et al. [19]. Reactions were analyzed by electrophoresis through
12% polyacrylamide/16 TBE mini-gels. The relative RecUMge
(resolution) activity (Fig. 5C) was expressed as percentage of the
protein’s activity in the absence of RuvAMge.
DNA helicase and ATPase assays
DNA helicase assays were performed similarly as described
before [18]. After deproteinization, the reactions mixtures were
analyzed by electrophoresis through 12% polyacrylamide/16
TBE mini-gel and fluorometry. The ATPase activities of RuvBFH
and RuvBMge were determined by using a b-nicotinamide adenine
dinucleotide reduced form (NADH)-coupled assay on a VersaMax
Tunable Microplate Reader (Molecular Devices) [15,46].
Supporting Information
Figure S1 RuvAMge is a tetramer in solution. (A) Gel
filtration analysis of RuvAMge. Gel filtration chromatography was
performed in a similar fashion as described previously [16], using
a Sephadex G-150 column (length, 1.0 m; inner diameter,
1.0 cm). The column was run at 4 ml/h in 50 mM Tris-HCl
(pH 7.5)/ 135 mM NaCl, and calibrated with blue dextran (2,000
kDa), bovine serum albumin (BSA, 66.4 kDa), ovalbumin (42.9
kDa), and cytochrome C (12.3 kDa). Fractions of 1.0 ml were
collected and monitored by measuring the optical density at
280 nm (OD280, Y-axis at the left-hand side of the graph). The
fractions eluted from a subsequent run, containing 15 mgo f
RuvAMge, were precipitated with trichloroacetic acid, and
separated on 12% SDS-PAGE gels. Gels were silver-stained and
recorded using the GelDoc XR system. RuvAMge was quantified by
densitometry using Quantity OneH 1-D Analysis Software (Bio-
Rad). The relative concentration of RuvAMge (Y-axis on the right-
hand side, in arbitrary units) is shown for column fractions 23 to
39. In all other fractions, RuvAMge was not detected. (B)
Calibration curve obtained from the gel filtration experiment
shown in (A). The molecular weight of protein size standards (¤)i s
plotted against the elution volume (Ve) divided by the void volume
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PLoS ONE | www.plosone.org 12 May 2012 | Volume 7 | Issue 5 | e38301(V0) of the column (Ve/V0). V0 was determined with blue dextran.
The Ve/V0 of RuvAMge is marked on the calibration curve (6).
(TIF)
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